389 related articles for article (PubMed ID: 17333608)
21. Drug use and risk behaviour profile, and the prevalence of HIV, hepatitis C and hepatitis B among people with methamphetamine use in Iran.
Moradi G; Hajarizadeh B; Rahmani K; Mohamadi-Bolbanabad A; Darvishi S; Zareie B; Zavareh FA; Sharafi H; Alavian SM; Ramazani R; Eftekhar M; Radfar SR; Piroozi B; Gouya MM
Int J Drug Policy; 2019 Nov; 73():129-134. PubMed ID: 31654935
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of HIV, syphilis, hepatitis B, and hepatitis C among entrants to Maryland correctional facilities.
Solomon L; Flynn C; Muck K; Vertefeuille J
J Urban Health; 2004 Mar; 81(1):25-37. PubMed ID: 15047781
[TBL] [Abstract][Full Text] [Related]
23. High-risk drug-use practices among a large sample of Australian prisoners.
Kinner SA; Jenkinson R; Gouillou M; Milloy MJ
Drug Alcohol Depend; 2012 Nov; 126(1-2):156-60. PubMed ID: 22658284
[TBL] [Abstract][Full Text] [Related]
24. History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection among injecting drug users in Berlin.
Stark K; Bienzle U; Vonk R; Guggenmoos-Holzmann I
Int J Epidemiol; 1997 Dec; 26(6):1359-66. PubMed ID: 9447418
[TBL] [Abstract][Full Text] [Related]
25. Association between heroin use, needle sharing and tattoos received in prison with hepatitis B and C positivity among street-recruited injecting drug users in New Mexico, USA.
Samuel MC; Doherty PM; Bulterys M; Jenison SA
Epidemiol Infect; 2001 Dec; 127(3):475-84. PubMed ID: 11811881
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis C antibody prevalence among Mexico City prisoners injecting legal and illegal substances.
Silverman-Retana O; Serván-Mori E; McCoy SI; Larney S; Bautista-Arredondo S
Drug Alcohol Depend; 2017 Dec; 181():140-145. PubMed ID: 29054033
[TBL] [Abstract][Full Text] [Related]
27. High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique.
Semá Baltazar C; Horth R; Boothe M; Sathane I; Young P; Chitsondzo Langa D; Condula M; Ricardo H; Dengo Baloi L; Cummings B; Schaad N; Gouveia L; Teodoro E; Raymond HF
BMC Infect Dis; 2019 Dec; 19(1):1022. PubMed ID: 31791273
[TBL] [Abstract][Full Text] [Related]
28. Prevalence and correlates of hepatitis C virus infection among injecting drug users in Tehran.
Zamani S; Ichikawa S; Nassirimanesh B; Vazirian M; Ichikawa K; Gouya MM; Afshar P; Ono-Kihara M; Ravari SM; Kihara M
Int J Drug Policy; 2007 Oct; 18(5):359-63. PubMed ID: 17854723
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factors.
Loebstein R; Mahagna R; Maor Y; Kurnik D; Elbaz E; Halkin H; Olchovsky D; Ezra D; Almog S
Isr Med Assoc J; 2008 Nov; 10(11):775-8. PubMed ID: 19070285
[TBL] [Abstract][Full Text] [Related]
30. Prevalence and incidence of bloodborne viral infections among Danish prisoners.
Christensen PB; Krarup HB; Niesters HG; Norder H; Georgsen J
Eur J Epidemiol; 2000; 16(11):1043-9. PubMed ID: 11421474
[TBL] [Abstract][Full Text] [Related]
31. Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004.
Burt RD; Hagan H; Garfein RS; Sabin K; Weinbaum C; Thiede H
J Urban Health; 2007 May; 84(3):436-54. PubMed ID: 17356901
[TBL] [Abstract][Full Text] [Related]
32. Screening for HIV, HBV and HCV markers among drug users in treatment in rural south-east England.
Edeh J; Spalding P
J Public Health Med; 2000 Dec; 22(4):531-9. PubMed ID: 11192282
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of antibodies to human immunodeficiency virus (HIV), hepatitis B and hepatitis C and risk factors in prisoners in Lebanon.
Mahfoud Z; Kassak K; Kreidieh K; Shamra S; Ramia S
J Infect Dev Ctries; 2010 Mar; 4(3):144-9. PubMed ID: 20351454
[TBL] [Abstract][Full Text] [Related]
34. Seroprevalence and Related Risk Behaviors of Hepatitis C, Hepatitis B and HIV Infections among Male Prisoners in Kermanshah, Iran.
Khademi N; Skakiba E; Khodadoust M; Khoramdad M
Arch Iran Med; 2019 Oct; 22(10):588-591. PubMed ID: 31679361
[TBL] [Abstract][Full Text] [Related]
35. Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy.
Babudieri S; Longo B; Sarmati L; Starnini G; Dori L; Suligoi B; Carbonara S; Monarca R; Quercia G; Florenzano G; Novati S; Sardu A; Iovinella V; Casti A; Romano A; Uccella I; Maida I; Brunetti B; Mura MS; Andreoni M; Rezza G
J Med Virol; 2005 Jul; 76(3):311-7. PubMed ID: 15902712
[TBL] [Abstract][Full Text] [Related]
36. Epidemiology of the viral hepatitis B and C in female prisoners of Metropolitan Regional Prison Complex in the State of Goiás, Central Brazil.
Barros LA; Pessoni GC; Teles SA; Souza SM; Matos MA; Martins RM; Del-Rios NH; Matos MA; Carneiro MA
Rev Soc Bras Med Trop; 2013; 46(1):24-9. PubMed ID: 23563821
[TBL] [Abstract][Full Text] [Related]
37. Low incidence of hepatitis C virus among prisoners in Scotland.
Taylor A; Munro A; Allen E; Dunleavy K; Cameron S; Miller L; Hickman M
Addiction; 2013 Jul; 108(7):1296-304. PubMed ID: 23297816
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of Hepatitis B and C among Drug-Abusing Male Prisoners in Birjand, South Khorasan, Iran.
Ghafari S; Sharifzadeh G; Jamali S; Taji B; Javadmoosavi SY; Ziaee M
Arch Iran Med; 2019 Sep; 22(9):501-504. PubMed ID: 31679371
[TBL] [Abstract][Full Text] [Related]
39. Harm reduction measures and injecting inside prison versus mandatory drugs testing: results of a cross sectional anonymous questionnaire survey. The European Commission Network on HIV Infection and Hepatitis in Prison.
Bird AG; Gore SM; Hutchinson SJ; Lewis SC; Cameron S; Burns S
BMJ; 1997 Jul; 315(7099):21-4. PubMed ID: 9233321
[TBL] [Abstract][Full Text] [Related]
40. Blood-borne and sexually transmitted infections: a cross-sectional study in a Swiss prison.
Chacowry Pala K; Baggio S; Tran NT; Girardin F; Wolff H; Gétaz L
BMC Infect Dis; 2018 Oct; 18(1):539. PubMed ID: 30373535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]